Analysis of the relationship between the use of traditional and complementary medical practices and health literacy levels in individuals with type II diabetes mellitus

Analysis of the relationship between the use of traditional and complementary medical practices and health literacy levels in individuals with type II diabetes mellitus

This research was conducted to examine the relationship between the use of Traditional and Complementary Medicine (TCM) and health literacy levels in individuals with Type II Diabetes Mellitus (DM). Ninetyeight patients staying in a university hospital between x and x and diagnosed with DM for at least one year were included in the study. Data were collected using a questionnaire (about patients’ individual characteristics, diseaserelated characteristics, and TCM-use) and the Turkey Health Literacy Scale-32 (THLS-32). The mean age of the patients was 57.73 ± 14.58 years, 65.3% were female, and 53.1% were receiving oral antidiabetic treatment. It was found that 19.4% used TCM. The most commonly used method (84.2%) was herbal medicine/product. Of the patients, 52.6% used TCM because they thought it would be effective in DM treatment, and 89.5% of this group considered using it again. It was found that 68.4% of the patients did not tell their doctor that they were using TCM. There was a statistically significant difference in the use of TCM in relation with the education level of the patients, working status, complications due to diabetes, and attending regular health check-ups (p

___

  • [1] Ayhan H, Mollahaliloğlu S. Tıbbi sülük tedavisi: hirudoterapi. Ankara Med J. 2018; 18(1): 141-148.
  • [2] Arslan M, Şahne BS, Şar S. Dünya’daki geleneksel tedavi sistemlerinden örnekler: genel bir bakış. Mersin Üniversitesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi. 2016; 6(3): 100-105.
  • [3] Kılıç KN, Soylar P. Investigation of attitudes, reasons and satisfaction levels of individuals who apply to traditional and complementary medicine practices. J Tradit Complem Med. 2019; 2(3): 97-105.
  • [4] Yukawa K, Ishikawa H, Yamazaki Y, Tsutani K, Kiuchi T. Patient health literacy and patient-physician communication regarding complementary and alternative medicine usage. Eur J Integr Med. 2017; 10: 38-45.
  • [5] Medine Y, Özonuk E. Relationship between health literacy and compliance with the treatment among individuals with type 2 diabetes mellitus. J Nurs Educ. 2019; 16(2): 96-103.
  • [6] Sheikhrabori A, Dehghan M, Ghaedi F, Khademi GR. Complementary and alternative medicine usage and its determinant factors among diabetic patients: an Iranian case. J Evid Based Complementary Altern Med. 2017; 22(3): 449-454.
  • [7] Radwan H, Hasan H, Hamadeh R, Hashim M, AbdulWahid Z, Hassanzadeh Gerashi M, Al Hilali M, Naja F. Complementary and alternative medicine use among patients with type 2 diabetes living in the United Arab Emirates. BMC Complement Med Ther. 2020; 20(216): 1-12.
  • [8] Joeliantina A, Soedirham O, Agil M, Qomaruddin M, Kusnanto K. A literature review of complementary and alternative medicine used among diabetes mellitus patients. Int J Public Health Sci. 2019; 8: 277-286.
  • [9] Karaman Ö, Cebe GE. Diyabet ve Türkiye’de Antidiyabetik olarak kullanılan bitkiler. Ankara Ecz Fak Derg. 2016; 40(3): 47-61.
  • [10] Pırıldar S. Mater Thesis. Aktarlarda satılan antidiyabetik etkili droglar üzerine araştırmalar. Department of Pharmacognosy, Faculty of Pharmacy, İstanbul University, İstanbul, Turkey, 2001.
  • [11] Benli Z. Hacamat tedavisi. Uluslararası Sosyal Bilimler Dergisi. 2017; 1(6): 46-53.
  • [12] Kutlubay Z, Engin B, Serdaroğlu S, Tüzün Y. Dermatolojide ozon tedavisi. Dermatoz. 2010; 1(4): 209-216
  • [13] Metcalfe A, Williams J, McChesney J, Patten SB, Jetté N. Use of complementary and alternative medicine by those with a chronic disease and the general population--results of a national population based survey. BMC Complement Altern Med. 2010; 10: 58.
  • [14] Güner TA, Kuzu A, Bayraktaroğlu T. Diyabetli bireylerde sağlık okuryazarlığı ve akılcı ilaç kullanımı arasındaki ilişki. Türk Diyab Obez. 2020; 4(3): 214-223.
  • [15] Atan G. Kronik hastalık yönetiminde tamamlayıcı ve alternatif tedavi kullanımı ve hemşirenin rolü. Van Sag Bil Derg. 2018; 11: 21-24.
  • [16] Chang H-YA, Wallis M, Tiralongo E. Predictors of complementary and alternative medicine use by people with type 2 diabetes. J Adv Nurs. 2012; 68(6): 1256-1266.
  • [17] Raja R, Kumar V, Khan MA, Sayeed KA, Hussain SZM, Rizwan A. Knowledge, attitude, and practices of complementary and alternative medication usage in patients of type ii diabetes mellitus. Cureus. 2019; 11(8): e5357.
  • [18] Şahin A, Dirgar E, Olgun N. Diyabet yönetiminde kullanılan tamamlayıcı ve alternatif tedaviler. Diyabet, Obezite ve Hipertansiyonda Hemşirelik Forumu Dergisi. 2019; 11(1): 32-36
  • [19] Kaynak İ, Polat Ü. Diabetes mellitus’lu hastaların tamamlayıcı ve alternatif tedavileri kullanma durumları ve diyabet tutumları ile ilişkisi. Genel Tıp Derg. 2017; 27(2): 56-64.
  • [20] Ceylan S, Azal O, Taşlipinar A, Türker T, Açikel CH, Gulec M. Complementary and alternative medicine use among Turkish diabetes patients. Complement Ther Med. 2009; 17(2): 78-83.
  • [21] Küçükgüçlü Ö, Kizilci S, Mert H, Uğur Ö, Besen DB, Ünsal E. Complementary and alternative medicine use among people with diabetes in Turkey. West J Nurs Res. 2012; 34(7): 902-916.
  • [22] Okyay P, Abacıgil F, Harlak H. Türkiye sağlık okuryaarlığı ölçeği-32. In: Okyay P, Abacıgil F. (Eds), Türkiye sağlık okuryazarlığı ölçekleri güvenirlik ve geçerlik çalışması. Anıl Reklam, Inc., Ankara, 2016, pp.43-61
Journal of research in pharmacy (online)-Cover
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: Marmara Üniversitesi
Sayıdaki Diğer Makaleler

Synthesis and evaluation of antibacterial and antimycobacterial activities of some new pyrazole derivatives

Erden BANOĞLU, Fatih DEMİRCİ, Serkan LEVENT, Tuğçe GÜR MAZ, Nursenem KARACA, Burcu ÇALIŞKAN

Formulation, characterization and in vitro release studies of terbinafine hydrochloride loaded buccal films

Muhammet Davut ARPA, Melike Zeynep ÜNÜKÜR, Ümit Can ERİM

Treatment of glioblastoma by photodynamic therapy with the aid of synthesized silver nanoparticles by green chemistry from Citrus aurantium

Salih PAŞA, Gizem DÖNMEZ YALÇIN, Mürüvvet ABBAK, Gülen Melike DEMİRBOLAT, Mehran AKSEL, Özge ÇEVİK, Ömer ERDOĞAN

Development of rasagiline mesylate loaded solid lipid nanoparticles in a thermosensitive mucoadhesive gel: Formulation design using DoE, in-vitro and ex-vivo characterization

Fahriye Figen TIRNAKSIZ, Mahmut Ozan TOKSOY

Design of an orally disintegrating tablet formulation containing metoprolol tartrate in the context of quality by design approach

Gizem YEĞEN, Buket AKSU, Erdal CEVHER

Determination of levetiracetam enantiomeric purity using HPLC-fluorescence detection coupled with a pre-column ophthalaldehyde-N-acetyl-L-cysteine derivatization

Mai RAMADAN

Alteration of neuropharmacological behavior by elemental zinc in healthy adult mice

Mohammad Salim HOSSAIN, Mohammad Tohidul AMIN, Atiqur RAHMAN, Sayema AREFIN, A.H.M. Mazbah UDDIN, Shafiullah BHUIYAN

Analytical QbD based systematic development of a novel RP-UHPLC method for the quantification of Albuterol sulphate in its metered dose inhaler formulations

Debashish GHOSE, Suryakanta SWAIN, Bikash Ranjan JENA, G.S.N. Koteswara RAO, Umasankar KULANDAIVELU, Rajasekhar Reddy ALAVALA, Siva Prasad PANDA, Gurudutta PATTNAIK, Debi Prasad PRADHAN

Investigation the effects of synthetic cannabinoid-AKB48 on DNA methylation via the regulation of cannabinoid receptor gene specific methylation in vitro

Şemsinur YİĞİTER, Sibel ÖZDEN, Ecem Fatma KARAMAN

Pyrrolо[1,2-a]azolo-(azino-)[c]quinazolines and their derivatives as 15-LOX inhibitors: Design, in vitro studies and QSAR-analysis

Oleksii VOSKOBOİNİK, Sergiy KOVALENKO, Natalia KRASOVSKA, Viktor STAVYTSKYI, Inna NOSULENKO, Sergiy KHOLODNIAK, Oleksii ANTYPENKO